Clinical Report: Utilizing Ultrasonography and Point Shear Wave Elastography Together for Evaluating Renal Disorders
Overview
This study demonstrates that point shear wave elastography (pSWE) can effectively assess renal stiffness across different chronic kidney disease (CKD) stages and etiologies. The findings indicate that pSWE provides valuable insights into renal disease severity and fibrosis, supporting its integration with conventional imaging techniques.
Background
Chronic Kidney Disease (CKD) is a significant global health issue, affecting 10-15% of the population and leading to severe complications such as end-stage renal disease (ESRD). Accurate assessment of renal health is crucial for timely intervention and management. Point shear wave elastography (pSWE) offers a non-invasive method to evaluate renal stiffness, which may correlate with disease severity and fibrosis.
Data Highlights
CKD Stage
Mean Elasticity (kPa)
Stage 1
5.0
Stage 2
6.0
Stage 3
7.0
Stage 4
8.5
Stage 5 (Hemodialysis)
9.8
Key Findings
Renal stiffness increased significantly from CKD stage 1 to stage 5 (p < 0.001).
pSWE-derived elasticity values varied significantly among different renal disease etiologies (p < 0.001).
pSWE values correlated positively with interstitial fibrosis score (r = 0.76) and glomerulosclerosis rate (r = 0.71).
pSWE measurements demonstrated high inter-operator (ICC 0.92) and intra-operator reliability (ICC 0.95).
Clinical Implications
The integration of pSWE with conventional ultrasound can enhance the evaluation of renal disorders, aiding in the differentiation of disease types and severity. This approach may reduce the need for invasive procedures like renal biopsies, improving patient care and outcomes.
Conclusion
pSWE is a promising tool for non-invasive assessment of renal stiffness, providing critical information for the management of chronic kidney disease. Its application alongside traditional imaging techniques can significantly enhance clinical decision-making.
